Financials

  • Market Capitalization 1.27 B
  • Employee 489
  • Founded 2007
  • CEO Mike Raab
  • Website www.ardelyx.com
  • Headquarter Delaware, United States
  • FIGI BBG001WH4DQ3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-24.96
Relación precio/flujo de caja
3.39

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2240
NVAX
Novavax, Inc. - Common Stock
8.42 USD-5.50%-9.27%-8.68%+21.68%1.38 B USD
2254
INBX
Inhibrx Biosciences, Inc. - Common Stock
93.21 USD+1.13%-7.71%+0.20%+15.67%1.37 B USD
2310
CRVS
Corvus Pharmaceuticals, Inc. - Common Stock
14.97 USD+1.77%-3.61%+21.02%+258.99%1.26 B USD
2315
IMTX
Immatics N.V. - Ordinary Shares
9.35 USD+1.30%-12.62%-0.74%-9.66%1.25 B USD

Noticias